Dirk Nehrbass received his diploma in veterinary medicine from the Justus-Liebig-University, Giessen (Germany), in 1994, did his thesis in basic medical research at the department for Cytopathology at the German Cancer Research Center in Heidelberg, and thereby obtained his veterinary doctoral degree, summa cum laude, in the year 2000 (best doctoral thesis of the academic year 2000/2001). In the following years he worked in veterinary diagnostics, certified for both, Veterinary Pathology and for Toxicopathology (FTA Pathology, Germany), and is board-eligible for the European College of Veterinary Pathology (ECVP). Since many years, he is a full member of several European pathology societies (ESTP, BSTP).
Functioning as a study pathologist at a private contract laboratory, and later as the head of the pathology department of biopharmaceutical company, as well as with the ARI, he has over ten years of practice under a GLP environment, providing him with a high-level of expertise in preclinical research as well as in drug and medical device development. Up to now, he has compiled over 250 reports on varying study types (discovery, toxicology, investigative, tissue cross reactivity, biodistribution [ADME], efficacy, local tolerance, surgical proof-of-concept) including all laboratory animal species and is author of more than 25 scientific publications, of several book chapters, and holds an international patent. In the last 10 years, he focused on exploratory and translational research on medical devices and specialized on studies on surgical products for clinics with special emphasis on the musculoskeletal system (e.g. tissue glues, implants like metal, ceramic, polymers, scaffolds).